These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31177221)

  • 1. Mitochondrial Movement and Number Deficits in Embryonic Cortical Neurons from 3xTg-AD Mice.
    Cavendish JZ; Sarkar SN; Colantonio MA; Quintana DD; Ahmed N; White BA; Engler-Chiurazzi EB; Simpkins JW
    J Alzheimers Dis; 2019; 70(1):139-151. PubMed ID: 31177221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
    Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease.
    Walker MP; LaFerla FM; Oddo SS; Brewer GJ
    Age (Dordr); 2013 Jun; 35(3):519-31. PubMed ID: 22237558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.
    Ghosh D; LeVault KR; Barnett AJ; Brewer GJ
    J Neurosci; 2012 Apr; 32(17):5821-32. PubMed ID: 22539844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers.
    Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2015 Aug; 1852(8):1665-75. PubMed ID: 25960150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
    Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
    J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Dependent Decline in Synaptic Mitochondrial Function Is Exacerbated in Vulnerable Brain Regions of Female 3xTg-AD Mice.
    Espino de la Fuente-Muñoz C; Rosas-Lemus M; Moreno-Castilla P; Bermúdez-Rattoni F; Uribe-Carvajal S; Arias C
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Onset of Sex-Dependent Mitochondrial Deficits in the Cortex of 3xTg Alzheimer's Mice.
    Djordjevic J; Roy Chowdhury S; Snow WM; Perez C; Cadonic C; Fernyhough P; Albensi BC
    Cells; 2020 Jun; 9(6):. PubMed ID: 32599904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Kv2.1 functioning promotes increased excitability in hippocampal neurons of an Alzheimer's disease mouse model.
    Frazzini V; Guarnieri S; Bomba M; Navarra R; Morabito C; Mariggiò MA; Sensi SL
    Cell Death Dis; 2016 Feb; 7(2):e2100. PubMed ID: 26890139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
    Beggiato S; Cassano T; Ferraro L; Tomasini MC
    Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
    Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM
    J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease.
    Omori C; Motodate R; Shiraki Y; Chiba K; Sobu Y; Kimura A; Nakaya T; Kondo H; Kurumiya S; Tanaka T; Yamamoto K; Nakajima M; Suzuki T; Hata S
    Nutr Neurosci; 2017 Nov; 20(9):538-546. PubMed ID: 27329428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease.
    Wang L; Guo L; Lu L; Sun H; Shao M; Beck SJ; Li L; Ramachandran J; Du Y; Du H
    PLoS One; 2016; 11(3):e0150441. PubMed ID: 26942905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
    Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent biochemical dysfunction in skeletal muscle of triple-transgenic mouse model of Alzheimer`s disease.
    Monteiro-Cardoso VF; Castro M; Oliveira MM; Moreira PI; Peixoto F; Videira RA
    Curr Alzheimer Res; 2015; 12(2):100-15. PubMed ID: 25654504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease.
    Adlimoghaddam A; Snow WM; Stortz G; Perez C; Djordjevic J; Goertzen AL; Ko JH; Albensi BC
    Neurobiol Dis; 2019 Jul; 127():264-277. PubMed ID: 30878533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease.
    Yu H; Wang D; Zou L; Zhang Z; Xu H; Zhu F; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Yang X
    Arch Toxicol; 2018 Apr; 92(4):1363-1382. PubMed ID: 29383422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.